BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15519475)

  • 21. Inducible clindamycin resistance in staphylococci isolated from clinical samples.
    Delialioglu N; Aslan G; Ozturk C; Baki V; Sen S; Emekdas G
    Jpn J Infect Dis; 2005 Apr; 58(2):104-6. PubMed ID: 15858290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular characterization of ketolide-resistant erm(A)-carrying Staphylococcus aureus isolates selected in vitro by telithromycin, ABT-773, quinupristin and clindamycin.
    Schmitz FJ; Petridou J; Jagusch H; Astfalk N; Scheuring S; Schwarz S
    J Antimicrob Chemother; 2002 Apr; 49(4):611-7. PubMed ID: 11909834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative in vitro activities of daptomycin, linezolid, and quinupristin/dalfopristin against Gram-positive bacterial isolates from a large cancer center.
    Smith PF; Booker BM; Ogundele AB; Kelchin P
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):255-9. PubMed ID: 15935606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The correlation between phenotypes and genotypes of macrolides, lincosamides and streptogramins B resistance in Staphylococcus aureus].
    Młynarczyk G; Młynarczyk A; Szymanek K; Bilewska A; Luczak M
    Med Dosw Mikrobiol; 2007; 59(1):17-25. PubMed ID: 17601027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Foggy D-shaped zone of inhibition in Staphylococcus aureus owing to a dual character of both inducible and constitutive resistance to macrolide-lincosamide-streptogramin B.
    Yoon EJ; Kwon AR; Min YH; Choi EC
    J Antimicrob Chemother; 2008 Mar; 61(3):533-40. PubMed ID: 18230691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparative in-vitro evaluation of resistance selection after exposure to teicoplanin, vancomycin, linezolid and quinupristin-dalfopristin in Staphylococcus aureus and Enterococcus spp.
    Drago L; Nicola L; De Vecchi E
    Clin Microbiol Infect; 2008 Jun; 14(6):608-11. PubMed ID: 18397336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and mechanisms of macrolide resistance among Staphylococcus epidermidis isolates from neutropenic patients in Tunisia.
    Bouchami O; Achour W; Ben Hassen A
    Clin Microbiol Infect; 2007 Jan; 13(1):103-6. PubMed ID: 17184298
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative in vitro activity of antiribosomal agents on penicillin-susceptible and -resistant Streptococcus pneumoniae in relation to their resistance genotypes.
    Sener B; Köseoglu O
    Int J Antimicrob Agents; 2004 Jul; 24(1):39-42. PubMed ID: 15225859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro activity of daptomycin against clinical isolates with reduced susceptibilities to linezolid and quinupristin/dalfopristin.
    Anastasiou DM; Thorne GM; Luperchio SA; Alder JD
    Int J Antimicrob Agents; 2006 Nov; 28(5):385-8. PubMed ID: 17046205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Susceptibility to daptomycin, quinupristin-dalfopristin and linezolid and some other antibiotics in clinical isolates of methicillin resistant and methicillin sensitive S.aureus from the Oslo area.
    Jørgen B; Merckoll P; Melby KK
    Scand J Infect Dis; 2007; 39(11-12):1059-62. PubMed ID: 17852934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A review of in-vitro antibacterial activity of quinupristin/dalfopristin against methicillin-susceptible and -resistant Staphylococcus aureus.
    Low DE; Nadler HL
    J Antimicrob Chemother; 1997 May; 39 Suppl A():53-8. PubMed ID: 9511063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In-vitro activity of quinupristin/dalfopristin, levofloxacin and moxifloxacin against fusidic acid and rifampicin-resistant strains of methicillin-resistant Staphylococcus aureus (MRSA) from Malaysian hospitals.
    Norazah A; Lim VK; Rohani MY; Kamel AG
    Med J Malaysia; 2005 Oct; 60(4):411-5. PubMed ID: 16570701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular basis of resistance to macrolides and lincosamides among staphylococci and streptococci from various animal sources collected in the resistance monitoring program BfT-GermVet.
    Lüthje P; Schwarz S
    Int J Antimicrob Agents; 2007 May; 29(5):528-35. PubMed ID: 17307339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of inducible cross-resistance to macrolides, lincosamides, and streptogramin B-type antibiotics in Enterococcus faecium on activity of quinupristin-dalfopristin in vitro and in rabbits with experimental endocarditis.
    Fantin B; Leclercq R; Garry L; Carbon C
    Antimicrob Agents Chemother; 1997 May; 41(5):931-5. PubMed ID: 9145847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of quinupristin/dalfopristin versus vancomycin, alone or in combination with rifampicin, against methicillin-resistant Staphylococcus aureus in a rabbit arthritis model.
    Hamel A; Caillon J; Jacqueline C; Batard E; Potel G
    Int J Antimicrob Agents; 2008 Feb; 31(2):158-60. PubMed ID: 18006281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Macrolide-lincosamide-streptogramin B resistance phenotypes in clinical staphylococcal isolates.
    Cetin ES; Gunes H; Kaya S; Aridogan BC; Demirci M
    Int J Antimicrob Agents; 2008 Apr; 31(4):364-8. PubMed ID: 18206352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative activity of the new lipoglycopeptide telavancin in the presence and absence of serum against 50 glycopeptide non-susceptible staphylococci and three vancomycin-resistant Staphylococcus aureus.
    Leuthner KD; Cheung CM; Rybak MJ
    J Antimicrob Chemother; 2006 Aug; 58(2):338-43. PubMed ID: 16787952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular analysis of constitutively expressed erm(C) genes selected in vitro by incubation in the presence of the noninducers quinupristin, telithromycin, or ABT-773.
    Schmitz FJ; Petridou J; Astfalk N; Köhrer K; Scheuring S; Schwarz S
    Microb Drug Resist; 2002; 8(3):171-7. PubMed ID: 12363005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Differentiation of resistance phenotypes among erythromycin-resistant streptococci].
    Bejuk D
    Acta Med Croatica; 2004; 58(4):301-6. PubMed ID: 15700686
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unusual resistance patterns in macrolide-resistant Streptococcus pyogenes harbouring erm(A).
    Malhotra-Kumar S; Mazzariol A; Van Heirstraeten L; Lammens C; de Rijk P; Cornaglia G; Goossens H
    J Antimicrob Chemother; 2009 Jan; 63(1):42-6. PubMed ID: 18952616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.